,
your personalized virtual assistant to find clinical trials. Go head, 
Robert Raju, Site 030
Dayton Oncology And HematologyKettering, Ohio - 45409 |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS2
- SINCE2008
Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive HER2-negative Post-menopausal Breast Cancer That is Unresectable Locally Recurrent or Metastatic
October 2008 - August 2011
Breast Neoplasms
Dasatinib + Letrozole
Letrozole
